Dr. Stephen P. Pound
OB-GYN (Obstetrics & Gynecology) (Obstetrics & Gynecology Physician)
- Medicare participating
At a glance
- Years since graduation
- 17
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 220
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Obstetrics & Gynecology Physician primary
VA license 0101253987
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: OB-GYN (Obstetrics & Gynecology) per capita by county →
Where they work
Hospitals
- Cjw Medical Center Richmond, VA
Medical groups
- Virginia Physicians for Women, LTD (47 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 220
- Services billed
- 605
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Screening 3d breast mammography | 112 | 112 |
| Screening mammography | 110 | 110 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 73 | 73 |
| Established patient office or other outpatient visit, 20-29 minutes | 62 | 52 |
| Automated urinalysis test | 60 | 56 |
| Established patient office or other outpatient visit, 30-39 minutes | 25 | 22 |
| Dxa bone density measurement of hip, pelvis, spine | 23 | 23 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 23 | 21 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 22 | 22 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Estradiol Other prescribers in North Chesterfield, VA | 64 |
| Alendronate Sodium Other prescribers in North Chesterfield, VA | 27 |
| Fluconazole Other prescribers in North Chesterfield, VA | 26 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in North Chesterfield, VA | 23 |
| Valacyclovir (valacyclovir hcl) Other prescribers in North Chesterfield, VA | 21 |
| Nystatin Other prescribers in North Chesterfield, VA | 19 |
| Premarin (estrogens, conjugated) Other prescribers in North Chesterfield, VA | 16 |
| Estradiol (Once Weekly) (estradiol) Other prescribers in North Chesterfield, VA | 13 |
| Triamcinolone Acetonide Other prescribers in North Chesterfield, VA | 13 |
| Venlafaxine Hcl Er (venlafaxine hcl) Other prescribers in North Chesterfield, VA | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 14 payments worth $265 in total to this clinician.
| Biogen, Inc. | $59.15 |
|---|---|
| Astellas Pharma US Inc | $33.47 |
| Pfizer Inc. | $26.24 |
| Lilly USA, LLC | $24.77 |
| Mayne Pharma Commercial LLC | $24.06 |
| Sumitomo Pharma America, Inc. | $23.67 |
| Organon LLC | $23.10 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.22 |
| Food and Beverage | $265 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 2 companies. The companies reported $82,360 in research payments for these studies, mostly to the institutions running them.
- Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
AbbVie Inc. · Active, not recruiting · NCT04333576 - A phase 3 study to investigate the safety tolerability and immunogenicity of revaccinating pregnant participants during subsequent pregnancies and persistence of immunity of a single dose of a bivalent respiratory syn…
Pfizer Inc. - A phase 3 randomized placebocontrolled doubleblinded trial to evaluate the safety tolerability and immunogenicity of a multivalent group b streptococcus vaccine in healthy pregnant women and their infants
Pfizer Inc. - M18-969 - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Sev…
AbbVie Inc. - M16-283 - Long-Term Safety Study of Elagolix in Combination With Estradiol Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie Inc. - Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.